我科自1992年1月至7月应用我院基因工程室生产的白细胞介素Ⅱ孵育自体LAK细胞治疗慢性乙型肝炎12例,以观察HBsAg、HBeAg及抗-HBc的转阴情况,现小结如下。 一、治疗情况。 本组12例,男10例,女2例,年龄20～55岁,均为慢性乙型肝炎,治疗前查乙肝免疫五项指标结果HBsAg、HBeAg、抗-HBc均阳性,查肝功能均有不同程度异常。治疗时每例每次采血100ml,分离血浆,红、白血球及淋巴细 Our department from January 1992 to July application of our hospital gene engineering studio production of interleukin II autologous LAK cells in the treatment of chronic hepatitis B in 12 cases to observe the HBsAg, HBeAg and anti-HBc negative situation, is the summary as follows. First, the treatment. The group of 12 patients, 10 males and 2 females, aged 20 to 55 years old, are chronic hepatitis B, check the five indicators of hepatitis B before treatment results HBsAg, HBeAg, anti-HBc were positive, check the liver function Different degrees of abnormalities. Each treatment of blood samples every 100ml, isolated plasma, red, white blood cells and lymphocytes